AJU IB Investment Co., Ltd.

Position in ACLX — Arcellx, Inc.

CIK 1710065 Seoul, M5

Position in ACLX

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$25,660,662

+$11,089,375 QoQ

Shares Held

223,486

0.0% QoQ

Ownership

0.382%

of shares outstanding

% of Portfolio

85.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

AJU IB Investment Co., Ltd. holds $29,915,942 across 5 Biotechnology names. ACLX ranks #1 (85.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc. This page	223,486	$25,660,662
2	KYMR	Kymera Therapeutics, Inc.	19,648	$1,636,481
3	SEER	Seer, Inc.	816,375	$1,371,510
4	RLYB	Rallybio Corp	94,334	$846,175
5	XLO	Xilio Therapeutics, Inc.	47,695	$401,114

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$25,660,662	223,486	0.0%	Shares	Sole	2026-05-08
2025-12-31	$14,571,287	223,486	-78.7%	Shares	Sole	2026-02-10
2025-09-30	$86,004,429	1,047,557	0.0%	Shares	Sole	2025-11-06
2025-06-30	$68,981,628	1,047,557	0.0%	Shares	Sole	2025-07-10
2025-03-31	$68,719,739	1,047,557	0.0%	Shares	Sole	2025-04-08
2024-12-31	$80,337,146	1,047,557	-24.1%	Shares	Sole	2025-04-08
2022-09-30	$25,919,305	1,380,890	0.0%	Shares	Sole	2022-11-14
2022-06-30	$24,966,491	1,380,890	0.0%	Shares	Sole	2022-08-09
2022-03-31	$19,360,077	1,380,890	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.